Square (SQ) PT Raised to $45 at Nomura/Instinet

Nomura/Instinet raised its price target on Square (NYSE: SQ) to $45.00 (from $33.00) while maintaining a Buy rating.

Analyst Dan Dolev sees further upside following YTD outperformance relative to the broader market. The analyst is expecting a "stellar" H2 and sees Adj. EBITDA reaching $145-150 million. Over the LT Dolev suspect the company's attractive total cost of ownership ought to result in a positive inflection in GPV growth which is his primary medium-term catalysts.

You May Also Be Interested In

• Unicycive Therapeutics (UNCY) PT Raised to $15 at Benchmark Following Q2 Results
• Deutsche Bank Starts Ardagh Metal Packaging S.A. (AMBP) at Hold
• Deutsche Bank Upgrades Target Hospitality (TH) to Buy